Site Search

Haita Makanji, vice president, clinical strategy and innovation supporting the specialty division of Magellan Rx Management, has worked for MRx for nearly 10 years, where she has focused on […]

Magellan’s Haita Makanji, vice president, clinical specialty solutions, was featured in Managed Healthcare Executive this week, discussing some ground breaking new gene therapies that are available for hemophilia sufferers. These therapies […]

[…] highlight the early results achieved with Health New England through our hemophilia management program,” said Haita Makanji, vice president, clinical specialty solutions at Magellan Rx Management. “Through personalized interventions, we’re […]